{"id":313909,"date":"2025-08-12T12:33:13","date_gmt":"2025-08-12T12:33:13","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/313909\/"},"modified":"2025-08-12T12:33:13","modified_gmt":"2025-08-12T12:33:13","slug":"sanofi-interrompt-la-fourniture-de-praluent-en-chine-avec-la-trop-forte-demande-12-08-2025-a-1346","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/313909\/","title":{"rendered":"Sanofi interrompt la fourniture de Praluent en Chine avec la trop forte demande – 12\/08\/2025 \u00e0 13:46"},"content":{"rendered":"

\"Le<\/p>\n

Le logo de Sanofi<\/p>\n

\n Sanofi a annonc\u00e9 mardi avoir cess\u00e9 l’approvisionnement en Chine de Praluent, son m\u00e9dicament contre le cholest\u00e9rol conjointement d\u00e9velopp\u00e9 avec Regeneron Pharmaceuticals, en raison d’une disponibilit\u00e9 limit\u00e9e.\n<\/p>\n

\n L’augmentation de la demande a conduit \u00e0 une disponibilit\u00e9 limit\u00e9e en Chine et dans certains autres pays, dit Sanofi, qui ajoute dans un communiqu\u00e9 transmis \u00e0 Reuters que l’approvisionnement de Praluent en Chine a d\u00e9j\u00e0 \u00e9t\u00e9 interrompu.\n<\/p>\n

\n Le groupe fran\u00e7ais n’a pas pr\u00e9cis\u00e9 quand l’approvisionnement reprendrait.\n<\/p>\n

\n Sanofi explique avoir investi pour renforcer la production mondiale de Praluent afin de r\u00e9pondre \u00e0 l’acc\u00e9l\u00e9ration de la croissance de la demande au cours des deux derni\u00e8res ann\u00e9es.\n<\/p>\n

\n Le groupe pr\u00e9cise que des experts cliniques ont constat\u00e9 que d’autres m\u00e9dicaments figurant sur la liste nationale des m\u00e9dicaments remboursables de Chine sont s\u00fbrs et indiqu\u00e9s pour les patients actuellement trait\u00e9s par Praluent.\n<\/p>\n

\n Sanofi ajoute travailler avec les prestataires de soins de sant\u00e9 en Chine pour assurer la transition.\n<\/p>\n

\n D’autres groupes pharmaceutiques ont cess\u00e9 de fournir des m\u00e9dicaments populaires \u00e0 la Chine. Merck a ainsi suspendu en f\u00e9vrier les livraisons de son vaccin phare contre le papillomavirus humain, Gardasil, invoquant la faiblesse des d\u00e9penses discr\u00e9tionnaires.\n<\/p>\n

\n (R\u00e9dig\u00e9 par Andrew Silver, version fran\u00e7aise Etienne Breban, \u00e9dit\u00e9 par Augustin Turpin)<\/p>\n","protected":false},"excerpt":{"rendered":"Le logo de Sanofi Sanofi a annonc\u00e9 mardi avoir cess\u00e9 l’approvisionnement en Chine de Praluent, son m\u00e9dicament contre…\n","protected":false},"author":2,"featured_media":313910,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[400,398,408,35,405,33,34,1011,27,403,402,399,404,401,406,407],"class_list":{"0":"post-313909","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-economie","8":"tag-action-cac-40","9":"tag-bourse-de-paris","10":"tag-boursorama","11":"tag-business","12":"tag-cotations","13":"tag-economie","14":"tag-economy","15":"tag-fr","16":"tag-france","17":"tag-indices-devises","18":"tag-investir","19":"tag-investissement","20":"tag-marche-boursier","21":"tag-sicav","22":"tag-trackers","23":"tag-warrants"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/115015818285722931","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/313909","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=313909"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/313909\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/313910"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=313909"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=313909"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=313909"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}